Abstract Recent outbreaks of Cutaneous Leishmaniasis (CL) in Waziristan make the disease
a public health concern in Khyber Pakhtunkhwa (KPK) province, Pakistan. The awareness …

In Brazil, the main strategy adopted to contain Visceral Leishmaniasis (VL) is the
controversial culling of dogs with reagent serology for Canine VL (CVL). Despite there are …

Abstract Clioquinol (5-chloro-7-iodoquinolin-8-ol or ICHQ) was recently showed to presents
an in vitro effective antileishmanial action, causing changes in membrane permeability …

Leishmaniasis is one of the deadliest neglected tropical diseases affecting 12–15 million
people worldwide, especially in middle-and low-income countries. Rapid and accurate …

Leishmaniasis is a vector‐borne disease caused by around 20 species of Leishmania. The
main clinical forms of leishmaniasis are cutaneous leishmaniasis (CL) and visceral …

Infant and young child skin diseases are among the most common features of morbidity
throughout the tropics. Because the skin is directly exposed to the environment, it is …

The present works reviewed the existing information on leishmaniasis in Sri Lanka and in
other countries, focusing on challenges of controlling leishmaniasis in the country, in an …

Background Visceral Leishmaniasis (VL), a severe parasitic disease, could be fatal if
diagnosis and treatment is delayed. Post kala-azar dermal leishmaniasis (PKDL), a skin …

Human tegumentary leishmaniasis (HTL) is a serious tropical disease caused by
Leishmania amazonensis. Developing new leishmanicidal agents can help overcome …

In the present study, a conserved Leishmania hypothetical protein, namely LiHypA, was
evaluated for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and …